Precursors of human CD4 cytotoxic T lymphocytes identified by single-cell transcriptome analysis.

Veena S Patil, Ariel Madrigal, Benjamin J Schmiedel, James Clarke, Patrick O'Rourke, Aruna D de Silva, Eva Harris, Bjoern Peters, Gregory Seumois, Daniela Weiskopf, Alessandro Sette, Pandurangan Vijayanand
Author Information
  1. Veena S Patil: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. ORCID
  2. Ariel Madrigal: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
  3. Benjamin J Schmiedel: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. ORCID
  4. James Clarke: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
  5. Patrick O'Rourke: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
  6. Aruna D de Silva: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. ORCID
  7. Eva Harris: Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720, USA. ORCID
  8. Bjoern Peters: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. ORCID
  9. Gregory Seumois: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. ORCID
  10. Daniela Weiskopf: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. ORCID
  11. Alessandro Sette: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. ORCID
  12. Pandurangan Vijayanand: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. vijay@lji.org. ORCID

Abstract

CD4 cytotoxic T lymphocytes (CD4-CTLs) have been reported to play a protective role in several viral infections. However, little is known in humans about the biology of CD4-CTL generation, their functional properties, and heterogeneity, especially in relation to other well-described CD4 memory T cell subsets. We performed single-cell RNA sequencing in more than 9000 cells to unravel CD4-CTL heterogeneity, transcriptional profile, and clonality in humans. Single-cell differential gene expression analysis revealed a spectrum of known transcripts, including several linked to cytotoxic and costimulatory function that are expressed at higher levels in the T (effector memory T cells expressing CD45RA) subset, which is highly enriched for CD4-CTLs, compared with CD4 T cells in the central memory (T) and effector memory (T) subsets. Simultaneous T cell antigen receptor (TCR) analysis in single cells and bulk subsets revealed that CD4-T cells show marked clonal expansion compared with T and T cells and that most of CD4-T were dengue virus (DENV)-specific in donors with previous DENV infection. The profile of CD4-T was highly heterogeneous across donors, with four distinct clusters identified by the single-cell analysis. We identified distinct clusters of CD4-CTL effector and precursor cells in the T subset; the precursor cells shared TCR clonotypes with CD4-CTL effectors and were distinguished by high expression of the interleukin-7 receptor. Our identification of a CD4-CTL precursor population may allow further investigation of how CD4-CTLs arise in humans and, thus, could provide insights into the mechanisms that may be used to generate durable and effective CD4-CTL immunity.

References

  1. Cell. 2017 Jun 15;169(7):1342-1356.e16 [PMID: 28622514]
  2. J Immunol. 2004 Aug 1;173(3):1834-41 [PMID: 15265915]
  3. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [PMID: 16199517]
  4. J Virol. 2014 Dec;88(24):14232-40 [PMID: 25275131]
  5. Genome Biol. 2015 Dec 10;16:278 [PMID: 26653891]
  6. Nat Rev Immunol. 2016 Feb;16(2):90-101 [PMID: 26688349]
  7. Blood. 2002 Nov 15;100(10):3698-702 [PMID: 12393723]
  8. Emerg Infect Dis. 2009 Feb;15(2):192-9 [PMID: 19193262]
  9. Nat Commun. 2015 Sep 25;6:8306 [PMID: 26404698]
  10. J Immunol. 2006 Dec 1;177(11):7515-9 [PMID: 17114419]
  11. Nat Methods. 2014 Jul;11(7):740-2 [PMID: 24836921]
  12. Front Immunol. 2017 Mar 24;8:325 [PMID: 28392788]
  13. Science. 2003 Nov 7;302(5647):1041-3 [PMID: 14605368]
  14. Front Immunol. 2017 Jan 23;8:19 [PMID: 28167943]
  15. J Clin Microbiol. 2007 Nov;45(11):3777-80 [PMID: 17804661]
  16. J Immunol. 2014 Sep 15;193(6):2931-40 [PMID: 25092889]
  17. Nat Med. 2002 Apr;8(4):379-85 [PMID: 11927944]
  18. J Biol Chem. 2006 Jun 9;281(23):16006-15 [PMID: 16608855]
  19. Immunol Lett. 2012 May 30;144(1-2):7-15 [PMID: 22425747]
  20. Eur J Immunol. 2005 Mar;35(3):738-45 [PMID: 15724249]
  21. Proc Natl Acad Sci U S A. 2010 May 25;107(21):9777-82 [PMID: 20457902]
  22. Nat Rev Immunol. 2012 Jan 20;12(2):136-48 [PMID: 22266691]
  23. Nat Immunol. 2016 Jun;17 (6):728-39 [PMID: 27089380]
  24. Eur J Immunol. 2013 Nov;43(11):2797-809 [PMID: 24258910]
  25. Science. 2010 Feb 26;327(5969):1098-102 [PMID: 20185720]
  26. Trends Cell Biol. 2004 Aug;14(8):461-9 [PMID: 15308213]
  27. Eur J Immunol. 2015 Oct;45(10):2762-5 [PMID: 26440905]
  28. Proc Natl Acad Sci U S A. 2013 May 28;110(22):E2046-53 [PMID: 23580623]
  29. Blood. 2004 Mar 15;103(6):2238-47 [PMID: 14645006]
  30. J Immunol. 2002 Jun 1;168(11):5954-8 [PMID: 12023402]
  31. Nat Immunol. 2005 Dec;6(12):1236-44 [PMID: 16273099]
  32. J Immunol. 2005 May 15;174(10):6088-94 [PMID: 15879103]
  33. J Infect Dis. 2016 Oct 1;214(7):1117-24 [PMID: 27443615]
  34. J Biol Chem. 2006 Dec 29;281(52):40389-98 [PMID: 17074767]
  35. Immunity. 2010 Aug 27;33(2):229-40 [PMID: 20727791]
  36. J Immunol. 2016 Jul 15;197(2):655-64 [PMID: 27271570]
  37. J Virol. 2012 Jun;86(12):6792-803 [PMID: 22491469]
  38. Front Immunol. 2015 Jun 25;6:327 [PMID: 26161083]
  39. Nat Rev Immunol. 2012 Nov;12(11):749-61 [PMID: 23080391]
  40. J Clin Invest. 2012 Aug;122(8):2847-56 [PMID: 22820287]
  41. Nat Commun. 2017 Jan 16;8:14049 [PMID: 28091601]
  42. J Virol. 2007 Jan;81(2):945-53 [PMID: 17079288]
  43. J Immunol. 1998 Dec 15;161(12):6451-4 [PMID: 9862665]
  44. MBio. 2016 Jul 19;7(4): [PMID: 27435464]
  45. Eur J Immunol. 2015 Oct;45(10):2945-58 [PMID: 26179882]
  46. Mem Inst Oswaldo Cruz. 1990 Jul-Sep;85(3):347-51 [PMID: 2134709]
  47. Eur J Immunol. 1998 Dec;28(12):4409-17 [PMID: 9862378]
  48. Nat Immunol. 2003 Dec;4(12):1191-8 [PMID: 14625547]
  49. J Virol. 2006 Apr;80(7):3532-40 [PMID: 16537621]
  50. Nat Immunol. 2017 Aug;18(8):940-950 [PMID: 28628092]
  51. J Immunol. 2003 Jun 15;170(12):5876-85 [PMID: 12794113]
  52. Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63 [PMID: 26195744]
  53. Semin Immunol. 2013 Nov 15;25(4):273-81 [PMID: 24246226]
  54. Nat Methods. 2014 Jun;11(6):653-5 [PMID: 24793455]
  55. Nat Med. 2011 Sep 18;17(10):1290-7 [PMID: 21926977]
  56. Nat Protoc. 2014 Jan;9(1):171-81 [PMID: 24385147]
  57. PLoS Comput Biol. 2015 Nov 25;11(11):e1004503 [PMID: 26606115]
  58. Oncogene. 2016 Nov 17;35(46):5942-5952 [PMID: 26686083]
  59. J Viral Hepat. 2006 Aug;13(8):505-14 [PMID: 16901280]
  60. Semin Immunol. 2004 Jun;16(3):205-12 [PMID: 15130505]
  61. PLoS Pathog. 2016 Jul 27;12 (7):e1005786 [PMID: 27463517]
  62. Nat Biotechnol. 2015 May;33(5):495-502 [PMID: 25867923]
  63. J Virol. 2004 Aug;78(16):8844-51 [PMID: 15280492]
  64. J Gen Virol. 2011 Dec;92(Pt 12):2746-56 [PMID: 21813708]
  65. PLoS One. 2012;7(1):e30397 [PMID: 22291950]
  66. Am J Transplant. 2008 Mar;8(3):627-36 [PMID: 18294159]
  67. Brain. 2015 Apr;138(Pt 4):902-17 [PMID: 25665584]
  68. Cell. 2015 Dec 3;163(6):1400-12 [PMID: 26607794]
  69. J Immunol. 2005 May 15;174(10):5926-30 [PMID: 15879083]
  70. Bioinformatics. 2015 Oct 15;31(20):3380-2 [PMID: 26099264]
  71. J Exp Med. 2016 Jan 11;213(1):123-38 [PMID: 26694968]
  72. Nat Methods. 2016 Apr;13(4):329-332 [PMID: 26950746]
  73. Genome Biol. 2014;15(12):550 [PMID: 25516281]

Grants

  1. U19 AI168631/NIAID NIH HHS
  2. R24 AI108564/NIAID NIH HHS
  3. S10 RR027366/NCRR NIH HHS
  4. HHSN272200900042C/NIAID NIH HHS
  5. P01 AI106695/NIAID NIH HHS
  6. HHSN272201400045C/NIAID NIH HHS
  7. U19 AI118610/NIAID NIH HHS
  8. R01 HL114093/NHLBI NIH HHS
  9. U19 AI118626/NIAID NIH HHS

MeSH Term

CD4-Positive T-Lymphocytes
Gene Expression Profiling
Humans
Immunologic Memory
Leukocytes, Mononuclear
Lymphocyte Activation
Receptors, Antigen, T-Cell
Single-Cell Analysis
T-Lymphocytes, Cytotoxic
Transcriptome

Chemicals

Receptors, Antigen, T-Cell